Drug
2-HOBA
2-HOBA is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)
Phase Distribution
Ph not_applicable
4
67%
Ph phase_2
2
33%
Phase Distribution
0
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution6 total trials
Phase 2Efficacy & side effects
2(33.3%)
N/ANon-phased studies
4(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Active(1)
Completed(5)
Detailed Status
Completed5
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 22 (33.3%)
N/A4 (66.7%)
Trials by Status
not_yet_recruiting117%
completed583%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_2
2-HOBA Phase 2 Clinical Trial in Rheumatoid Arthritis
NCT05274243
not_yet_recruitingphase_2
Clinical Trial of 2-HOBA in Pulmonary Arterial Hypertension
NCT06176118
completednot_applicable
2-HOBA: Multiple Dosing Study in Older Adults
NCT03556319
completednot_applicable
2-HOBA: Multiple Dosing Study in Healthy Humans
NCT03555682
completednot_applicable
Brain Penetrance of 2-HOBA in Humans
NCT03554096
Clinical Trials (6)
Showing 6 of 6 trials
NCT05274243Phase 2
2-HOBA Phase 2 Clinical Trial in Rheumatoid Arthritis
NCT06176118Phase 2
Clinical Trial of 2-HOBA in Pulmonary Arterial Hypertension
NCT03556319Not Applicable
2-HOBA: Multiple Dosing Study in Older Adults
NCT03555682Not Applicable
2-HOBA: Multiple Dosing Study in Healthy Humans
NCT03554096Not Applicable
Brain Penetrance of 2-HOBA in Humans
NCT03176940Not Applicable
2-HOBA: Initial Evaluation in Humans
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6